12
NEWS
Fuelling innovation
Bukhman Foundation commits $12m to the T1D Fund to
fuel the next wave of innovation in Type 1 diabetes.
The Bukhman Foundation
has announced a $12m
donation to the T1D Fund:
A Breakthrough T1D
Venture, LLC. Donation underscores
commitment to advancing medical
research toward life-changing
breakthroughs for people living with
Type 1 diabetes (T1D).
The T1D Fund is the first
and largest scaled venture fund
established to catalyse the
development of T1D cure-oriented
therapies. The Bukhman Foundation's
contribution to the T1D Fund is
part of its £100m pledge to advance
groundbreaking T1D research and
treatment worldwide.
Since announcing the pledge
earlier this year, the Bukhman
Foundation has supported various
initiatives in partnership with Diabetes
UK, Breakthrough T1D, and most
recently the creation of the Bukhman
Centre for Research Excellence in T1D
at the University of Oxford.
This transformative gift supports
the T1D Fund's new $150+ million
capital raise, endorsing its higherconviction
investment strategy. The
Fund is intensifying its efforts to
catalyse investment in transformative
cures and increase the volume and
pace of T1D innovation.
"We are deeply committed
to unlocking life-changing
breakthroughs for the millions of
people living with T1D worldwide,"
said Anastasia Bukhman, CoFounder
of the Bukhman Foundation.
"Our donation reflects a strong
commitment to the T1D community,
and confidence in the T1D Fund's
investment strategy and world
class team driving progress toward
treatments, prevention, and,
ultimately, a cure. We look forward to
the continued progress of the Fund,
building on our existing commitment
and decade-long support of
Breakthrough T1D."
Unmet needs
The Bukhman Foundation was
established in 2023 by Anastasia
and Igor Bukhman to help improve
lives and generate positive impact to
people and their communities. The
foundation focuses on T1D medical
research, supporting open science,
long-term collaboration and visionary
thinking; and arts and culture,
celebrating and expanding access,
and helping the next generation of
artists and cultural professionals to
be represented, be innovative and
excel.
In 2025, the foundation
announced an historic £100 million
pledge over the next 10 years to
advance research and advocacy in
T1D. By backing innovative projects
and fostering collaboration among
top researchers, the Bukhman
Foundation's aim is to spearhead
efforts to address the unmet needs
of millions of people living with T1D
worldwide. bukhmanfoundation.org